Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.39 EUR | -0.71% | -3.47% | -65.25% |
Sales 2024 * | 650K 698K | Sales 2025 * | 31.4M 33.71M | Capitalization | 50.27M 53.98M |
---|---|---|---|---|---|
Net income 2024 * | -20M -21.47M | Net income 2025 * | -1M -1.07M | EV / Sales 2024 * | 150 x |
Net Debt 2024 * | 47.5M 51M | Net Debt 2025 * | 17.7M 19M | EV / Sales 2025 * | 2.16 x |
P/E ratio 2024 * |
-2.37
x | P/E ratio 2025 * |
-28
x | Employees | 62 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 76.24% |
Latest transcript on Sequana Medical N.V.
1 week | -5.08% | ||
Current month | -6.98% | ||
1 month | -17.65% | ||
3 months | -59.54% | ||
6 months | -48.34% | ||
Current year | -65.00% |
Managers | Title | Age | Since |
---|---|---|---|
Ian Crosbie
CEO | Chief Executive Officer | 56 | 15-12-31 |
Director of Finance/CFO | 50 | - | |
Andreas Wirth
CTO | Chief Tech/Sci/R&D Officer | 56 | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Douglas Kohrs
BRD | Director/Board Member | 66 | 22-07-18 |
Wim Ottevaere
BRD | Director/Board Member | 68 | 18-11-07 |
Ids van der Weij
BRD | Director/Board Member | - | Nov. 09 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 1.39 | -0.71% | 45 796 |
24-04-25 | 1.4 | 0.00% | 17,476 |
24-04-24 | 1.4 | -1.06% | 17,617 |
24-04-23 | 1.415 | -1.05% | 44,506 |
24-04-22 | 1.43 | -0.69% | 22,362 |
Real-time Euronext Bruxelles, April 25, 2024 at 11:35 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-65.00% | 53.85M | |
+1.12% | 42.59B | |
+6.77% | 40.65B | |
+45.26% | 40.57B | |
-11.96% | 26.77B | |
+6.01% | 24.81B | |
-24.92% | 18.17B | |
-3.63% | 11.7B | |
+27.16% | 12.05B | |
+7.30% | 11.1B |
- Stock Market
- Equities
- SEQUA Stock